retatrutide source forum Safety, Side Effects & Provider Use Retatrutide and the Grey Market:

The Payer Perspective: Payers, including insurers and healthcare systems, are becoming increasingly discerning when it comes to covering pharmaceutical treatments, especially for chronic conditions like obesity and diabetes

Both are effective

They dont prescribe compounded GLP-1s, which means youre getting the exact same medications used in the landmark clinical trials

GLP-1RAs can reduce the development of macroalbuminuria and reduce the estimated glomerular filtration rate (eGFR) decline in participants with T2D [54, 55].This reduction is attributed to various mechanisms, including the reduction of oxidative stress and inflammation and inhibition of the immune systems response